Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
What to Expect in a GLP-1 Maintenance Consultation
)
one Published Research The SURMOUNT and SURPASS trial programs provide extensive published documentation: SURMOUNT-1 through SURMOUNT-4: Obesity indication trials SURPASS-1 through SURPASS-5: Diabetes indication trials Extensive real-world evidence from post-marketing surveillance Published literature across multiple populations and demographics Retatrutide: GLP-1 + GIP + Glucagon Retatrutide represents the most comprehensive receptor coverage, activating all three pathways that Mazdutide and Tirzepatide divide between them
We can dispense up to 12 weeks of medication at a time
Of 53,943 patients screened, 1,021 met inclusion criteria
US$ 21.32
US$ 27.30
US$ 27.70
US$ 27.87
US$ 24.08
US$ 21.20
